A Look at the Glaucoma Armamentarium
Media formats available:
Details
Presenters
Overview
NoneSupported by unrestricted educational grants from Aerie Pharmaceuticals and Bausch + Lomb. Learning Objectives
At the completion of this educational activity, you will be better able to: - Identify the mechanisms of action as well as the efficacy and safety profiles of novel trabecular outflow medications.
- Demonstrate proficiency in selecting appropriate therapies to achieve individualized patient-specific treatment goals.
- Advocate for patients who would benefit from new drugs before they are incorporated into payors’ formularies.
Accreditation
Accreditation Statement Evolve Medical Education LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.Credit Designation Statement Evolve Medical Education LLC designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This course is COPE approved for 1.0 hour of CE credit for optometrists.Sponsored by: State University of New York College of Optometry Evolve is an approved COPE Administrator. COPE Course ID: 66659-GL COPE Event ID: 118883Faculty and Disclosures
DISCLOSURE POLICY
Jason Bacharach, MD Director, Glaucoma Division California Pacific Medical Center San Francisco, California Medical Director & Founding Partner North Bay Eye Associates Inc. Sonoma County, California Dr. Bacharach and/or spouse has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Aerie Pharmaceuticals, Allergan, Bausch + Lomb, Ellex, EyePoint Pharmaceuticals, Glaukos, New World Medical, Optovue, and Osmotica. Grant/Research Support: Aerie Pharmaceuticals, Allergan, Bausch + Lomb, Biorasi, Equinox, Eyepoint Pharmaceuticals, Glaukos, Nicox, Optovue, Santen, and Sun. Speaker’s Bureau: Alcon, Allergan, Glaukos, and New World Medical. Stock/Shareholder: Aerie Pharmaceuticals, Injectsense, and Osmotica. Albert S. Khouri, MD Associate Professor of Ophthalmology Director, Glaucoma Service Director, Ophthalmology Residency Rutgers New Jersey Medical School Newark, New Jersey Dr. Khouri and/or spouse has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Aerie Pharmaceuticals, Glaukos, and Eyenovia. Speaker’s Bureau: Aerie Pharmaceuticals, Allergan, and Bausch + Lomb. Grant Support: Allergan, Optovue, and NJ Health Foundation. Editorial Support Disclosures
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.- Erin K. Fletcher, MIT, director of compliance and education, Evolve, has no financial relationships with commercial interests.
- Susan Gallagher-Pecha, director of client services and project management, Evolve, has no financial relationships with commercial interests.
- Cassandra Richards, director of education development, Evolve, has no financial relationships with commercial interests.
- Nisha Mukherjee, MD, peer reviewer, has no financial relationships with commercial interests.
Disclaimer
OFF-LABEL STATEMENT This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. DISCLAIMER The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve Medical Education LLC, Aerie Pharmaceuticals, or Bausch + Lomb. System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
- Apple Safari for Mac OS and iOS
- Mozilla Firefox for Windows, Mac OS, iOS, and Android
- Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Release Date:
Expiration Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!